ASTH
Price
$29.50
Change
-$0.20 (-0.67%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
1.37B
52 days until earnings call
CHE
Price
$464.00
Change
-$1.63 (-0.35%)
Updated
Sep 8, 04:59 PM (EDT)
Capitalization
6.79B
51 days until earnings call
Interact to see
Advertisement

ASTH vs CHE

Header iconASTH vs CHE Comparison
Open Charts ASTH vs CHEBanner chart's image
Astrana Health
Price$29.50
Change-$0.20 (-0.67%)
Volume$7.67K
Capitalization1.37B
Chemed
Price$464.00
Change-$1.63 (-0.35%)
Volume$2.95K
Capitalization6.79B
ASTH vs CHE Comparison Chart in %
Loading...
ASTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASTH vs. CHE commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASTH is a Buy and CHE is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 09, 2025
Stock price -- (ASTH: $29.70 vs. CHE: $465.63)
Brand notoriety: ASTH and CHE are both not notable
Both companies represent the Hospital/Nursing Management industry
Current volume relative to the 65-day Moving Average: ASTH: 94% vs. CHE: 119%
Market capitalization -- ASTH: $1.36B vs. CHE: $6.76B
ASTH [@Hospital/Nursing Management] is valued at $1.36B. CHE’s [@Hospital/Nursing Management] market capitalization is $6.76B. The market cap for tickers in the [@Hospital/Nursing Management] industry ranges from $97.83B to $0. The average market capitalization across the [@Hospital/Nursing Management] industry is $4.06B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASTH’s FA Score shows that 1 FA rating(s) are green whileCHE’s FA Score has 0 green FA rating(s).

  • ASTH’s FA Score: 1 green, 4 red.
  • CHE’s FA Score: 0 green, 5 red.
According to our system of comparison, ASTH is a better buy in the long-term than CHE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASTH’s TA Score shows that 4 TA indicator(s) are bullish while CHE’s TA Score has 7 bullish TA indicator(s).

  • ASTH’s TA Score: 4 bullish, 6 bearish.
  • CHE’s TA Score: 7 bullish, 2 bearish.
According to our system of comparison, CHE is a better buy in the short-term than ASTH.

Price Growth

ASTH (@Hospital/Nursing Management) experienced а -7.07% price change this week, while CHE (@Hospital/Nursing Management) price change was +1.68% for the same time period.

The average weekly price growth across all stocks in the @Hospital/Nursing Management industry was +70.39%. For the same industry, the average monthly price growth was +69.45%, and the average quarterly price growth was +78.85%.

Reported Earning Dates

ASTH is expected to report earnings on Oct 30, 2025.

CHE is expected to report earnings on Oct 29, 2025.

Industries' Descriptions

@Hospital/Nursing Management (+70.39% weekly)

Hospital/Nursing Management companies own and operate health care facilities. Their operations include nursing homes, acute care facilities, retirement centers and outpatient surgery centers. HCA Healthcare Inc., Alcon Inc. and Universal Health Services, Inc. are some major companies in this industry. Technology has been at the forefront of development of advanced solutions, including quicker diagnoses of complex conditions. Investments in new diagnostics, healthcare IoT, and other healthcare technologies continue to gather momentum in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHE($6.79B) has a higher market cap than ASTH($1.37B). ASTH has higher P/E ratio than CHE: ASTH (57.12) vs CHE (23.96). ASTH YTD gains are higher at: -5.804 vs. CHE (-11.833). CHE has higher annual earnings (EBITDA): 453M vs. ASTH (112M). ASTH has more cash in the bank: 342M vs. CHE (250M). CHE has less debt than ASTH: CHE (146M) vs ASTH (448M). CHE (2.51B) and ASTH (2.42B) have equivalent revenues.
ASTHCHEASTH / CHE
Capitalization1.37B6.79B20%
EBITDA112M453M25%
Gain YTD-5.804-11.83349%
P/E Ratio57.1223.96238%
Revenue2.42B2.51B96%
Total Cash342M250M137%
Total Debt448M146M307%
FUNDAMENTALS RATINGS
ASTH vs CHE: Fundamental Ratings
ASTH
CHE
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
76
Overvalued
69
Overvalued
PROFIT vs RISK RATING
1..100
87100
SMR RATING
1..100
8839
PRICE GROWTH RATING
1..100
4463
P/E GROWTH RATING
1..100
1274
SEASONALITY SCORE
1..100
1275

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CHE's Valuation (69) in the Medical Or Nursing Services industry is in the same range as ASTH (76) in the null industry. This means that CHE’s stock grew similarly to ASTH’s over the last 12 months.

ASTH's Profit vs Risk Rating (87) in the null industry is in the same range as CHE (100) in the Medical Or Nursing Services industry. This means that ASTH’s stock grew similarly to CHE’s over the last 12 months.

CHE's SMR Rating (39) in the Medical Or Nursing Services industry is somewhat better than the same rating for ASTH (88) in the null industry. This means that CHE’s stock grew somewhat faster than ASTH’s over the last 12 months.

ASTH's Price Growth Rating (44) in the null industry is in the same range as CHE (63) in the Medical Or Nursing Services industry. This means that ASTH’s stock grew similarly to CHE’s over the last 12 months.

ASTH's P/E Growth Rating (12) in the null industry is somewhat better than the same rating for CHE (74) in the Medical Or Nursing Services industry. This means that ASTH’s stock grew somewhat faster than CHE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASTHCHE
RSI
ODDS (%)
Bearish Trend 4 days ago
62%
Bullish Trend 5 days ago
71%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
80%
Bearish Trend 4 days ago
51%
Momentum
ODDS (%)
Bearish Trend 4 days ago
73%
Bullish Trend 4 days ago
59%
MACD
ODDS (%)
Bearish Trend 4 days ago
76%
Bullish Trend 4 days ago
38%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
75%
Bullish Trend 4 days ago
51%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
52%
Advances
ODDS (%)
Bullish Trend 11 days ago
79%
Bullish Trend 4 days ago
47%
Declines
ODDS (%)
Bearish Trend 6 days ago
74%
Bearish Trend 14 days ago
49%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
83%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
81%
Bullish Trend 4 days ago
43%
View a ticker or compare two or three
Interact to see
Advertisement
ASTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CHE
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MSEGX64.300.80
+1.26%
Morgan Stanley Inst Growth A
MECEX14.870.03
+0.20%
NYLI Epoch Capital Growth Class C
UIVAX20.360.01
+0.05%
Victory Value Institutional
JDVSX16.90-0.01
-0.06%
JPMorgan Diversified I
VFFSX317.85-0.97
-0.30%
Vanguard 500 Index Institutional Select

ASTH and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASTH has been loosely correlated with ACHC. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if ASTH jumps, then ACHC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASTH
1D Price
Change %
ASTH100%
-3.63%
ACHC - ASTH
45%
Loosely correlated
+0.30%
DCGO - ASTH
40%
Loosely correlated
+4.64%
LFST - ASTH
35%
Loosely correlated
-1.83%
AMN - ASTH
35%
Loosely correlated
+3.06%
AIRS - ASTH
35%
Loosely correlated
-0.34%
More

CHE and

Correlation & Price change

A.I.dvisor indicates that over the last year, CHE has been loosely correlated with OPCH. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CHE jumps, then OPCH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHE
1D Price
Change %
CHE100%
+1.29%
OPCH - CHE
45%
Loosely correlated
+1.08%
DVA - CHE
40%
Loosely correlated
+1.70%
ADUS - CHE
32%
Poorly correlated
+1.22%
NHC - CHE
31%
Poorly correlated
-0.18%
ASTH - CHE
28%
Poorly correlated
-3.63%
More